CN204798405U - Modular tablet - Google Patents
Modular tablet Download PDFInfo
- Publication number
- CN204798405U CN204798405U CN201520248660.1U CN201520248660U CN204798405U CN 204798405 U CN204798405 U CN 204798405U CN 201520248660 U CN201520248660 U CN 201520248660U CN 204798405 U CN204798405 U CN 204798405U
- Authority
- CN
- China
- Prior art keywords
- lobe
- recess
- tablet
- combination type
- fixed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
An object of the utility model is to provide a modular tablet, including the tablet body, set up the bellying on tablet body first interface to and the recess of setting on tablet body second contact surface, the bellying with the recess convex -concave corresponds, the size of bellying and recess can be fixed for the bellying and held in the recess. The utility model provides a modular tablet, it increases single medicine dose when once taking medicine among the prior art or accomplishes different medicine compounds and dose to take medicine for the patient and plague and the inappropriate problem of drug dose to have solved.
Description
Technical field
This utility model relates to a kind of pharmaceutical products, is specifically related to a kind of combination type tablet.
Background technology
Along with development and the growth in the living standard of social economy, science and technology, while crowd's life-span increases, cardio-cerebrovascular disorder sickness rate increases.Most Patients with geriatric cardiovascular and cerebrovascular diseases needs to take more than a kind of medicine in daily life, common are antiplatelet, blood pressure lowering, blood fat reducing and adjusts heart rate, improves cardiac function oral formulations.Existing external producer addresses that need the monolithic compound preparation developing different antihypertensive drugs, antihypertensive drugs and fat-reducing medicament at present, the composition of medicine of suitable compatibility can reduce dosage and the side reaction of the application of single medicine, and achieves good curative effect on clinical and evidence-based medicine EBM.But the proportioning of two kinds of medicines in monolithic tablet is fixed, be unfavorable for carrying out individualized adjustment according to conditions of patients and curative effect.Such as, valsartan-hydrochlorothiazide monolithic compound preparation is with being in the treatment of 160/100mmHg patient for basic blood pressure level, and some patient's lower limbs edema are even more serious and to fixed dosage diuretic Low Response, needs the dosage increasing hydrochlorothiazide.Now, apply compound preparation if double, add the consumption of valsartan, too much vasodilative effect may make patients' blood too low simultaneously; Then make this patient apply monolithic compound preparation with hydrochlorothiazide to become and make an unnecessary move if add again on the basis of application compound preparation.In addition, same medicine increases dosage and patient's single medication number is increased, and the unhappiness also multi-disc being brought to take medicine to patient is experienced.
Utility model content
The purpose of this utility model is to provide a kind of combination type compound recipe tablet, and increasing single medicine dose or complete the administration of different pharmaceutical compound recipe when once taking medicine in solution prior art makes troubles to patient consumes and the inappropriate problem of drug dose.
For achieving the above object, the technical solution adopted in the utility model is:
A kind of combination type tablet, comprise tablet bulk, be arranged on the lobe on tablet bulk first interface, and the recess be arranged on tablet bulk second contact surface, described lobe is corresponding with the female portion convex-concave, and the size of described lobe and recess is that lobe can fixedly be contained in the female portion.
Preferably, described lobe is fixed in the female portion by fixed part.
Preferably, described fixed part is bonding part, and described bonding part is arranged in the female portion inside top surface or in described lobe exterior top surface, by bonding part, lobe is adhesively fixed in recess.
Preferably, described fixed part is threaded portion, and described threaded portion is arranged in the female portion inner side and on described lobe lateral surface, by threaded portion, lobe is screwed in and be fixed in recess.
Preferably, described fixed part is granule portion, and described granule portion is arranged on inner or described lobe outside, the female portion or is arranged on recess inside and described lobe outside simultaneously, by granule portion, lobe is fixed in recess.
Preferably, described fixed part is draw-in groove portion, arranges the draw-in groove matched respectively, lobe is fixed in recess on inside, the female portion and described lobe outside.
Preferably, described fixed part is projection-depressed part, arranges the projection and sunk structure that match respectively, lobe is fixed in recess on inside, the female portion and described lobe outside.
Preferably, described tablet bulk is flat lamellar.
Preferably, described tablet bulk circular in cross-section, rhombus or polygon.
Preferably, described tablet bulk is without corner angle.
The combination type tablet that this utility model provides, the lobe comprising tablet bulk and be arranged on tablet bulk and recess, by being fixedly connected with between lobe and recess, two or more tablet is combined, that measures by patient consumes needs combination tablet quantity, is convenient to the medicine that patient once takes combination in any dosage.
Accompanying drawing explanation
Fig. 1 is the integral perspective schematic diagram of this utility model combination type tablet embodiment 1;
Fig. 2 is the schematic cross-section of this utility model combination type tablet embodiment 1;
Fig. 3 is the integral perspective schematic diagram of this utility model combination type tablet embodiment 2;
Fig. 4 is the schematic cross-section of this utility model combination type tablet embodiment 2.
In figure: 1. tablet bulk, 2. the first interface, 3. second contact surface, 4. lobe, 5. recess, 6. lobe exterior top surface, 7. recess inside top surface, 8. bonding part.
Detailed description of the invention
Below in conjunction with accompanying drawing, the technical solution of the utility model is further described.
Embodiment 1
As shown in Figure 1-2, combination type tablet comprises tablet bulk 1, is arranged on the lobe 4 on tablet bulk 1 first interface 2, and is arranged on dotted portion in the recess 5, Fig. 1 on tablet bulk 1 second contact surface 3 and is the seen recess 5 of perspective; The lobe 4 of tablet bulk 1 and upper setting thereof and recess 5 consist of a monomer tablet, and described lobe 4 is corresponding with the female portion 5 convex-concave, and the size dimension of described lobe 4 and recess 5 is that lobe 4 can fixedly be contained in the female portion 5; Namely each monomer tablet is upper and lower all can be fixedly connected with another monomer tablet, forms combination in series.Described lobe 4 and recess 5 are at size dimension, corresponding, consistent in shape, and plural monomer tablet is combined by the mutually chimeric of lobe 4 and recess 5 matching structure.Patient can combine the drug administration of various dose on demand, comprise different size tablet of the same race and can compatibility application different tablets, administered in combination.Be easy to patient take, be particularly useful for the patients needing once to take multi-disc, multi-medicament.
Wherein, monomer tablet can be a kind of medicine, also can be compound medicine.Be applicable to the patients of multi-medicament.
Described tablet bulk 1 is flat lamellar.After being beneficial to the combination of multiple monomer tablet, global shape is still convenient to take.
Described tablet bulk 1 circular in cross-section, rhombus or polygon, or other any shapes.Described cross section is that to overlook face be drug entity cross section under lobe 4 visual angle of monomer tablet.Described cross section is not limited to above-mentioned shape, rhombus or polygon, facilitates administered in combination, is convenient to the manufacturing, molding.
Described tablet bulk 1 passes through without corner angle process.Surface smoothing, conveniently swallows.And be not limited to without corner angle to the process of tablet bulk 1, also comprise other make coat tablets level and smooth, be convenient to the processing mode of swallowing.
Embodiment 2
As shown in Figure 3-4, on embodiment 1 basis, described lobe 4 is fixedly connected with by fixed part with between the female portion 5, in the present embodiment, fixed part is bonding part 8, described bonding part 8 is arranged in the female portion inside top surface 7 or in described lobe exterior top surface 6, by bonding part 8, lobe 4 is adhesively fixed in recess 5.Described bonding part 8 is edible adhesive, safe to eat, also can by two or more monomer tablet fixed Combination together.The present embodiment is except above-mentioned explanation, and other are all identical with embodiment 1.
Embodiment 3
On embodiment 1 basis, monomer tablet arranges fixed part, described fixed part is threaded portion, and described threaded portion is arranged in the female portion 5 inner side and on described lobe 4 lateral surface, by threaded portion, lobe 4 is screwed in and be fixed in recess 5.The present embodiment is except above-mentioned explanation, and other are all identical with embodiment 1.
Embodiment 4
On embodiment 1 basis, monomer tablet arranges fixed part, described fixed part is granule portion, described granule portion is arranged on inner or described lobe 4 outside, the female portion 5 or is arranged on recess 5 inside and described lobe 4 outside simultaneously, by granule portion, lobe 4 is fixed in recess 5.The present embodiment is except above-mentioned explanation, and other are all identical with embodiment 1.
Embodiment 5
On embodiment 1 basis, monomer tablet arranges fixed part, described fixed part is draw-in groove portion, arranges the draw-in groove matched respectively, lobe 4 is fixed in recess 5 on inside, the female portion 5 and described lobe 4 outside.The present embodiment is except above-mentioned explanation, and other are all identical with embodiment 1.
Embodiment 6
On embodiment 1 basis, monomer tablet arranges fixed part, described fixed part is projection-depressed part, arranges the projection and sunk structure that match respectively, lobe 4 is fixed in recess 5 on inside, the female portion 5 and described lobe 4 outside.The present embodiment is except above-mentioned explanation, and other are all identical with embodiment 1.
The fixed part be fixedly connected with between the monomer tablet of this utility model combination type medicine is not limited to the fixed part described in above-described embodiment, and other also can be adopted to make recess 5 be fixedly connected with lobe 4 and form the fixed part of multiple monomer tablet tandem compound.And this utility model above-described embodiment also can mutual combination collocation arbitrarily.
Set forth a lot of detail in the above description so that fully understand this utility model.But above description is only preferred embodiment of the present utility model, this utility model can be much different from alternate manner described here to implement, and therefore this utility model is not by the disclosed concrete restriction implemented above.Any those skilled in the art are not departing under technical solutions of the utility model ambit simultaneously, the Method and Technology content of above-mentioned announcement all can be utilized to make many possible variations and modification to technical solutions of the utility model, or be revised as the Equivalent embodiments of equivalent variations.Every content not departing from technical solutions of the utility model, according to technical spirit of the present utility model to any simple modification made for any of the above embodiments, equivalent variations and modification, all still belongs in the scope of technical solutions of the utility model protection.
Claims (10)
1. a combination type tablet, it is characterized in that, comprise tablet bulk, be arranged on the lobe on tablet bulk first interface, and the recess be arranged on tablet bulk second contact surface, described lobe is corresponding with the female portion convex-concave, and the size of described lobe and recess is that lobe can fixedly be contained in the female portion.
2. combination type tablet according to claim 1, is characterized in that, described lobe is fixed in the female portion by fixed part.
3. combination type tablet according to claim 2, it is characterized in that, described fixed part is bonding part, and described bonding part is arranged in the female portion inside top surface or in described lobe exterior top surface, by bonding part, lobe is adhesively fixed in recess.
4. combination type tablet according to claim 2, it is characterized in that, described fixed part is threaded portion, and described threaded portion is arranged in the female portion inner side and on described lobe lateral surface, by threaded portion, lobe is screwed in and be fixed in recess.
5. combination type tablet according to claim 2, it is characterized in that, described fixed part is granule portion, described granule portion is arranged on inner or described lobe outside, the female portion or is arranged on recess inside and described lobe outside simultaneously, by granule portion, lobe is fixed in recess.
6. combination type tablet according to claim 2, is characterized in that, described fixed part is draw-in groove portion, arranges the draw-in groove matched respectively, lobe is fixed in recess on inside, the female portion and described lobe outside.
7. combination type tablet according to claim 2, it is characterized in that, described fixed part is projection-depressed part, arranges the projection and sunk structure that match respectively, lobe is fixed in recess on inside, the female portion and described lobe outside.
8. combination type tablet according to claim 1, is characterized in that, described tablet bulk is flat lamellar.
9. combination type tablet according to claim 1, is characterized in that, described tablet bulk circular in cross-section, rhombus or polygon.
10. combination type tablet according to claim 1, is characterized in that, described tablet bulk is without corner angle.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520248660.1U CN204798405U (en) | 2015-04-22 | 2015-04-22 | Modular tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201520248660.1U CN204798405U (en) | 2015-04-22 | 2015-04-22 | Modular tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204798405U true CN204798405U (en) | 2015-11-25 |
Family
ID=54583306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201520248660.1U Active CN204798405U (en) | 2015-04-22 | 2015-04-22 | Modular tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN204798405U (en) |
-
2015
- 2015-04-22 CN CN201520248660.1U patent/CN204798405U/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021091721A5 (en) | ||
| CN106388964A (en) | Artificial tooth socket for slowly releasing medicament form | |
| CN204798405U (en) | Modular tablet | |
| CN104013272B (en) | A kind of Chinese medicinal pillow of Cure for insomnia | |
| CN109453169B (en) | Application of bulleyaconitine A | |
| CN104623416B (en) | A kind of traditional Chinese medicine health care preparation for being used to recuperate under medical treatment amnesia | |
| CN104546793B (en) | A kind of blood sugar lowering coprinus comatus capsule preparations and preparation method thereof | |
| US11331249B2 (en) | Devices for delivering an agent into breastmilk and associated systems and methods | |
| CN204723413U (en) | Portable medicine storage box | |
| CN206138377U (en) | Double -deck box of treatment | |
| CN107595849A (en) | A kind of antianxiety and the medical composition and its use for improving sleep | |
| CN204033817U (en) | A kind of premix Chinese medicine water-honeyed pill | |
| CN201389180Y (en) | Medicament inner package with prompting function | |
| JP2012530691A5 (en) | ||
| CN101244150B (en) | Medicament for treating enteritis | |
| CN105287960A (en) | Medicine for tonifying kidney and benefiting qi | |
| CN106174511A (en) | It is applicable to the health food of hyperpietic | |
| Villalba et al. | Ibuprofen gummies as a new pediatric dosage form | |
| CN205073322U (en) | Solid preparation of easily breaking into two with one's hands | |
| CN103083792B (en) | Plaster type oral esophagus medicine-applying treatment device and method | |
| CN105232659B (en) | A kind of Chinese medicine composition of soothing liver and strengthening spleen and preparation method thereof | |
| KR20190069077A (en) | Drugs that suppress the insulin intake | |
| JP2004210750A (en) | Biorhythm application kit | |
| CN104644940A (en) | Sanguis draconis traditional Chinese medicine preparation for treating diabetes mellitus | |
| CN203425264U (en) | Divisible tablet |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |